Objectives: This study sought to assess the efficacy of angiotensin-converting enzyme
inhibitors (ACEIs) in patients with coronary heart disease and preserved left ventricular (LV) …

Background Results of randomized trials of angiotensin-converting enzyme inhibitors in
patients with coronary artery disease (CAD) and preserved left ventricular function are …

The development of angiotensin-converting enzyme inhibitors (ACE inhibitors) has been
one of the most remarkable stories in the treatment of cardiovascular diseases. Angiotensin …

Background Angiotensin-converting–enzyme (ACE) inhibitors are effective in reducing the
risk of heart failure, myocardial infarction, and death from cardiovascular causes in patients …

Background: Patients with ischemic heart disease and preserved ventricular function
experience considerable morbidity and mortality despite standard medical therapy. Purpose …

Angiotensin-converting–enzyme (ACE) inhibitors are effective in reducing mortality and
morbidity from cardiovascular events among patients who have chronic heart failure due to …

Background Angiotensin-converting-enzyme (ACE) inhibitors reduce cardiovascular
mortality and morbidity in patients with heart failure or left ventricular systolic dysfunction …

Objectives To compare the efficacy and safety of angiotensin-converting enzyme inhibitors
(ACEis) and angiotensin receptor blockers (ARBs) in patients without heart failure. Patients …

BACKGROUND: The addition of an angiotensin receptor blocker (ARB) to an angiotensin-
converting enzyme inhibitor (ACEI) in patients with heart failure remains controversial. A …

Objective.—To evaluate the effect of angiotensin-converting enzyme (ACE) inhibitors on
mortality and morbidity in patients with symptomatic congestive heart failure. Data Sources …